{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:06:56Z","timestamp":1792109216100,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T00:00:00Z","timestamp":1129593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T00:00:00Z","timestamp":1129593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1038\/sj.mp.4001763","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T07:04:37Z","timestamp":1129619077000},"page":"187-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine"],"prefix":"10.1038","volume":"11","author":[{"given":"E T","family":"Tzavara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F P","family":"Bymaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C D","family":"Overshiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K W","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D L","family":"McKinzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Witkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G G","family":"Nomikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,10,18]]},"reference":[{"key":"BF4001763_CR1","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1016\/S0149-2918(03)90092-0","volume":"25","author":"J Caballero","year":"2003","unstructured":"Caballero J, Nahata MC . Atomoxetine hydrochloride for the treatment of attention-deficit\/hyperactivity disorder. Clin Ther 2003; 25: 3065\u20133083.","journal-title":"Clin Ther"},{"key":"BF4001763_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.psc.2003.12.001","volume":"27","author":"T Spencer","year":"2004","unstructured":"Spencer T, Biederman J, Wilens T . Nonstimulant treatment of adult attention-deficit\/hyperactivity disorder. Psychiatr Clin North Am 2004; 27: 373\u2013383.","journal-title":"Psychiatr Clin North Am"},{"key":"BF4001763_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.psych.48.1.649","volume":"48","author":"BJ Everitt","year":"1997","unstructured":"Everitt BJ, Robbins TW . Central cholinergic systems and cognition. Annu Rev Psychol 1997; 48: 649\u2013684.","journal-title":"Annu Rev Psychol"},{"key":"BF4001763_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0893-133X(01)00312-8","volume":"26","author":"J Ichikawa","year":"2002","unstructured":"Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY . Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 2002; 26: 325\u2013339.","journal-title":"Neuropsychopharmacology"},{"key":"BF4001763_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","volume":"26","author":"S Shirazi-Southall","year":"2002","unstructured":"Shirazi-Southall S, Rodriguez DE, Nomikos GG . Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 2002; 26: 583\u2013594.","journal-title":"Neuropsychopharmacology"},{"key":"BF4001763_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","volume":"27","author":"FP Bymaster","year":"2002","unstructured":"Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder. Neuropsychopharmacology 2002; 27: 699\u2013711.","journal-title":"Neuropsychopharmacology"},{"key":"BF4001763_CR7","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"1982","unstructured":"Paxinos G, Watson C . The Rat Brain in Stereotaxic Coordinates. Academic Press: New York, 1982."},{"key":"BF4001763_CR8","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/0024-3205(88)90475-4","volume":"43","author":"G Damsma","year":"1988","unstructured":"Damsma G, Westerink BH, de Boer P, de Vries JB, Horn AS . Basal acetylcholine release in freely moving rats detected by on-line trans-striatal dialysis: pharmacological aspects. Life Sci 1988; 43: 1161\u20131168.","journal-title":"Life Sci"},{"key":"BF4001763_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","volume":"138","author":"ET Tzavara","year":"2003","unstructured":"Tzavara ET, Davis RJ, Perry KW, Li X, Salhoff C, Bymaster FP et al. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br J Pharmacol 2003; 138: 544\u2013553.","journal-title":"Br J Pharmacol"},{"key":"BF4001763_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejphar.2003.08.025","volume":"477","author":"MC Wolff","year":"2003","unstructured":"Wolff MC, Leander JD . SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. Eur J Pharmacol 2003; 477: 213\u2013217.","journal-title":"Eur J Pharmacol"},{"key":"BF4001763_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1073\/pnas.91.2.777","volume":"91","author":"U Staubli","year":"1994","unstructured":"Staubli U, Rogers G, Lynch G . Facilitation of glutamate receptors enhances memory. Proc Natl Acad Sci USA 1994; 91: 777\u2013781.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001763_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/026988119901300210","volume":"13","author":"R Pussinen","year":"1999","unstructured":"Pussinen R, Sirvio J . Effects of cycloserine, a positive modulator of N-methyl-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behaviour of rats assessed in the radial arm maze. J Psychopharmacology 1999; 13: 171\u2013179.","journal-title":"J Psychopharmacology"},{"key":"BF4001763_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","volume":"31","author":"A Ennaceur","year":"1988","unstructured":"Ennaceur A, Delacour J . A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 1988; 31: 47\u201359.","journal-title":"Behav Brain Res"},{"key":"BF4001763_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF02245880","volume":"109","author":"A Ennaceur","year":"1992","unstructured":"Ennaceur A, Meliani K . Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests. Psychopharmacology (Berlin) 1992; 109: 321\u2013330.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BF4001763_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/BF02249415","volume":"125","author":"E Acquas","year":"1996","unstructured":"Acquas E, Fibiger HC . Chronic lithium attenuates dopamine D1-receptor mediated increases in acetylcholine release in rat frontal cortex. Psychopharmacology (Berlin) 1996; 125: 162\u2013167.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BF4001763_CR16","first-page":"360","volume":"281","author":"E Acquas","year":"1997","unstructured":"Acquas E, Wilson C, Fibiger HC . Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo. J Pharmacol Exp Ther 1997; 281: 360\u2013368.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF4001763_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0014-2999(77)90202-3","volume":"41","author":"M Raiteri","year":"1977","unstructured":"Raiteri M, Del Carmine R, Bertollini A, Levi G . Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol 1977; 41: 133\u2013143.","journal-title":"Eur J Pharmacol"},{"key":"BF4001763_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.1471-4159.1995.65010111.x","volume":"65","author":"PJ Gresch","year":"1995","unstructured":"Gresch PJ, Sved AF, Zigmond MJ, Finlay JM . Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 1995; 65: 111\u2013116.","journal-title":"J Neurochem"},{"key":"BF4001763_CR19","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1046\/j.1471-4159.1994.63062086.x","volume":"63","author":"JC Day","year":"1994","unstructured":"Day JC, Fibiger HC . Dopaminergic regulation of septohippocampal cholinergic neurons. J Neurochem 1994; 63: 2086\u20132092.","journal-title":"J Neurochem"},{"key":"BF4001763_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/syn.890120405","volume":"12","author":"J Day","year":"1992","unstructured":"Day J, Fibiger HC . Dopaminergic regulation of cortical acetylcholine release. Synapse 1992; 12: 281\u2013286.","journal-title":"Synapse"},{"key":"BF4001763_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/(SICI)1096-9861(19961028)374:4<535::AID-CNE5>3.0.CO;2-2","volume":"374","author":"L Zaborszky","year":"1996","unstructured":"Zaborszky L, Cullinan WE . Direct catecholaminergic-cholinergic interactions in the basal forebrain. I. Dopamine-beta-hydroxylase- and tyrosine hydroxylase input to cholinergic neurons. J Comp Neurol 1996; 374: 535\u2013554.","journal-title":"J Comp Neurol"},{"key":"BF4001763_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","volume":"68","author":"DS Auld","year":"2002","unstructured":"Auld DS, Kornecook TJ, Bastianetto S, Quirion R . Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 2002; 68: 209\u2013245.","journal-title":"Prog Neurobiol"},{"key":"BF4001763_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nn992","volume":"6","author":"SG Anagnostaras","year":"2003","unstructured":"Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, Nathanson NM et al. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 2003; 6: 51\u201358.","journal-title":"Nat Neurosci"},{"key":"BF4001763_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.mp.4001270","volume":"8","author":"ET Tzavara","year":"2003","unstructured":"Tzavara ET, Bymaster FP, Felder CC, Wade M, Gomeza J, Wess J et al. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2\/M4 muscarinic receptor knockout mice. Mol Psychiatry 2003; 8: 673\u2013679.","journal-title":"Mol Psychiatry"},{"key":"BF4001763_CR25","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1073\/pnas.1533498100","volume":"100","author":"S Granon","year":"2003","unstructured":"Granon S, Faure P, Changeux JP . Executive and social behaviors under nicotinic receptor regulation. Proc Natl Acad Sci USA 2003; 100: 9596\u20139601.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001763_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0165-0173(02)00268-0","volume":"41","author":"T Myhrer","year":"2003","unstructured":"Myhrer T . Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Brain Res Rev 2003; 41: 268\u2013287.","journal-title":"Brain Res Brain Res Rev"},{"key":"BF4001763_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF02245921","volume":"102","author":"JE Sweeney","year":"1990","unstructured":"Sweeney JE, Bachman ES, Coyle JT . Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice. Psychopharmacology (Berlin) 1990; 102: 191\u2013200.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BF4001763_CR28","first-page":"1","volume":"282","author":"JX Cai","year":"1997","unstructured":"Cai JX, Arnsten AFT . Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 1997; 282: 1\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF4001763_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s002130050768","volume":"140","author":"JF Flood","year":"1998","unstructured":"Flood JF, Uezu K, Morley JE . Effect of histamine H2 and H3 receptor modulation in the septum on post-training memory processing. Psychopharmacology (Berlin) 1998; 140: 279\u2013284.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BF4001763_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0091-3057(99)00205-1","volume":"65","author":"EF Popke","year":"2000","unstructured":"Popke EF, Mayorga AJ, Fogle CM, Paule MG . Effects of acute nicotine on several operant behaviors in rats. Pharmacol Biochem Behav 2000; 65: 247\u2013254.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF4001763_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0166-4328(01)00318-7","volume":"129","author":"JM Andersen","year":"2002","unstructured":"Andersen JM, Lindberg V, Myhrer T . Effects of scopolamine and D-cycloserine on non-spatial reference memory in rats. Behav Brain Res 2002; 129: 211\u2013216.","journal-title":"Behav Brain Res"},{"key":"BF4001763_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/syn.10143","volume":"47","author":"MS Lidow","year":"2003","unstructured":"Lidow MS, Koh P-O, Arnsten AFT . D1 dopamine receptors in the mouse prefrontal cortex: immunocytochemical and cognitive neuropharmacological analyses. Synapse 2003; 47: 101\u2013108.","journal-title":"Synapse"},{"key":"BF4001763_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF02244889","volume":"112","author":"TT Soncrant","year":"1993","unstructured":"Soncrant TT, Raffaele KC, Asthana S, Berardi A, Morris PP, Haxby JV . Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease. Psychopharmacology (Berlin) 1993; 112: 421\u2013427.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BF4001763_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0009-9236(96)90138-1","volume":"60","author":"N Canal","year":"1996","unstructured":"Canal N, Imbimbo BP . Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group. Clin Pharmacol Ther 1996; 60: 218\u2013228.","journal-title":"Clin Pharmacol Ther"},{"key":"BF4001763_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1527-3458.2001.tb00205.x","volume":"7","author":"D Braida","year":"2001","unstructured":"Braida D, Sala M . Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies. CNS Drug Rev 2001; 7: 369\u2013386.","journal-title":"CNS Drug Rev"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4001763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001763","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:09:21Z","timestamp":1648768161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4001763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,18]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2,1]]}},"alternative-id":["BF4001763"],"URL":"https:\/\/doi.org\/10.1038\/sj.mp.4001763","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,18]]},"assertion":[{"value":"29 March 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}